117 related articles for article (PubMed ID: 4995457)
1. [Treatment of viral infections during immunosuppression].
Fontaine J
Laval Med; 1970 Feb; 41(2):289-91. PubMed ID: 4995457
[No Abstract] [Full Text] [Related]
2. Prevention of infection after cardiac transplantation.
Décourt LV; Zerbini EJ
Laval Med; 1970 Feb; 41(2):285-8. PubMed ID: 4995456
[No Abstract] [Full Text] [Related]
3. Prevention of infections in transplantation patients.
Williams TW
Transplant Proc; 1972 Dec; 4(4):707-10. PubMed ID: 4630299
[No Abstract] [Full Text] [Related]
4. [Indications and choice of antibacterial treatment in patients receiving immunosuppressive agents and antimitotic drugs (author's transl)].
Frottier J; Kernbaum S; Verliac F; Bastin R
Pathol Biol (Paris); 1976 Feb; 24(2):141-8. PubMed ID: 775407
[TBL] [Abstract][Full Text] [Related]
5. Medical experiences with cardiac transplantation.
Schrire V
Cardiovasc Clin; 1971; 2(3):259-76. PubMed ID: 4950427
[No Abstract] [Full Text] [Related]
6. Patient isolation units for cancer patients treated with chemical immunosuppressive agents.
Bodey GP
Transplant Proc; 1973 Sep; 5(3):1279-84. PubMed ID: 4199579
[No Abstract] [Full Text] [Related]
7. [Possibilities and results of treatment in sterile environments].
Dietrich M
Med Klin; 1975 Jun; 70(23):1009-10. PubMed ID: 813098
[No Abstract] [Full Text] [Related]
8. Immunosuppression and virus infections.
Stevens DA
Transplant Proc; 1973 Sep; 5(3):1259-62. PubMed ID: 4353947
[No Abstract] [Full Text] [Related]
9. Treatment strategies for bacteria and viruses. Why clinical management must be different.
Weaving P
Nurs Times; 2006 Jun 13-19; 102(24):42-3. PubMed ID: 16827048
[No Abstract] [Full Text] [Related]
10. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
Vassilopoulos D; Calabrese LH
Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
[TBL] [Abstract][Full Text] [Related]
11. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.
Crespo-Leiro MG; Alonso-Pulpón L; Arizón JM; Almenar L; Delgado JF; Palomo J; Manito N; Rábago G; Lage E; Diaz B; Roig E; Pascual D; Blasco T; de la Fuente L; Campreciós M; Vázquez de Prada JA; Muñiz J
J Heart Lung Transplant; 2007 Nov; 26(11):1105-9. PubMed ID: 18022075
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic therapy and kidney transplantation].
Chapman A; Lebon P; Legrain M; Nedey R; Kuss R
Therapie; 1974; 29(3):387-98. PubMed ID: 4612857
[No Abstract] [Full Text] [Related]
13. [Bacteriologic management of patients with decreased resistance].
Hendriks WD; Sizoo W; Löwenberg B; Hagenbeek A
Ned Tijdschr Geneeskd; 1984 Feb; 128(7):305-10. PubMed ID: 6422314
[No Abstract] [Full Text] [Related]
14. [Virus infections during immunosuppressive therapy following organ transplantation].
Munk K; Runnebaum H
Dtsch Med Wochenschr; 1970 Oct; 95(44):2252-4. PubMed ID: 4324332
[No Abstract] [Full Text] [Related]
15. [Infectious complications after liver transplantation].
Moncorge C; Matmar M
Ann Radiol (Paris); 1994; 37(5):383-5. PubMed ID: 7993025
[TBL] [Abstract][Full Text] [Related]
16. Reverse isolation in bone marrow transplantation: ultra-clean room compared with laminar flow technique. II. Microbiological and clinical results.
Vossen JM; van der Waay D
Rev Eur Etud Clin Biol; 1972; 17(6):564-74. PubMed ID: 4630613
[No Abstract] [Full Text] [Related]
17. Current status of lung transplantation in Poland: experience of the Silesian Center for Heart Diseases.
Wojarski J; Jastrzebski D; Zembala M
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():245-9. PubMed ID: 16204800
[TBL] [Abstract][Full Text] [Related]
18. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.
Miller LW; Naftel DC; Bourge RC; Kirklin JK; Brozena SC; Jarcho J; Hobbs RE; Mills RM
J Heart Lung Transplant; 1994; 13(3):381-92; discussion 393. PubMed ID: 8061013
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation in man. The significance, patterns, and control of infection.
Murray-Lyon IM; Evans DB; Foster WD; Holden RJ; Rake MO; Stern H; Calne RY; Williams R
Br J Surg; 1970 Apr; 57(4):280-4. PubMed ID: 4985576
[No Abstract] [Full Text] [Related]
20. Cell mediated immunity (CMI) and post transplant viral infections--role of a functional immune assay to titrate immunosuppression.
Gautam A; Fischer SA; Yango AF; Gohh RY; Morrissey PE; Monaco AP
Int Immunopharmacol; 2006 Dec; 6(13-14):2023-6. PubMed ID: 17161357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
